Bone Cement and Glue - Global Strategic Business Report

Global Bone Cement and Glue Market to Reach $1.5 Billion by 2030

The global market for Bone Cement and Glue estimated at US$1 Billion in the year 2022, is projected to reach a revised size of US$1.5 Billion by 2030, growing at a CAGR of 5% over the analysis period 2022-2030. Bone Cement, one of the segments analyzed in the report, is projected to record 5.8% CAGR and reach US$1.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Bone Glue segment is readjusted to a revised 3.1% CAGR for the next 8-year period.

The U.S. Market is Estimated at $278.9 Million, While China is Forecast to Grow at 8.6% CAGR

The Bone Cement and Glue market in the U.S. is estimated at US$278.9 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$332.9 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 4.2% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Select Competitors (Total 42 Featured) -

• Arthrex, Inc.
• Cardinal Health, Inc.
• CryoLife, Inc.
• DePuy Synthes
• DJO Global, Inc.
• Exactech, Inc.
• Heraeus Medical LLC
• Smith & Nephew PLC
• Stryker Corporation
• Teknimed
• Trimph Pty Ltd
• Zimmer Biomet Holdings, Inc.

What's New?

• Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
• Global competitiveness and key competitor percentage market shares
• Market presence across multiple geographies - Strong/Active/Niche/Trivial
• Online interactive peer-to-peer collaborative bespoke updates
• Access to digital archives and Research Platform
• Complimentary updates for one year